Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Medullary 9 Thyroid Neoplasms 7 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡